American Chemical Society Publications
Information for ACS Authors about the NIH Public Access Policy Mandate
Effective April 7, 2008, authors whose studies are supported in whole or in part by NIH grant or contract
funding are required by law to submit electronic copies of their peer-reviewed manuscripts to the NIH’s
PubMed Central for public access 12 months after journal publication.
Three Options for NIH-Funded Authors
To enable ACS authors to comply with this mandatory NIH Public Access Policy, the ACS Publications
Division, after consultation with the Society’s governance, is instituting the use of a special NIH Policy
Addendum [PDF] to the ACS Copyright Status Form for use by NIH-funded authors. Copies also may be
obtained on request via our Help Desk, Copyright and Permissions office, and Columbus Journal Production
Operations. The NIH Policy Addendum [PDF] ensures full compliance with the NIH Public Access Policy and
covers all authors receiving NIH funding regardless of their place of work. Please be advised that alternate
addenda or modifications to the ACS Copyright Status Form will not be accepted in lieu of this NIH Policy
Addendum [PDF] for use by NIH-funded ACS authors.
In consulting the NIH Policy Addendum [PDF], you will see that ACS now offers NIH-funded authors three
options by which to fulfill the NIH Public Access policy requirement of manuscript deposit:
• Option A: ACS deposits the final, published article on the author's behalf, for immediate open
availability via the ACS AuthorChoice fee-based option. ACS AuthorChoice provides the
opportunity for authors to comply readily with the deposit and public access requirements of the NIH.
Moreover, by requesting that the ACS deliver the final published article to the NIH under the ACS
AuthorChoice license to the author, authors need not provide copies of peer-reviewed manuscript files
and supplemental information to the NIH's manuscript submission system, and can avoid the necessity
of performing subsequent proofreading tasks to check the fidelity of NIH's file conversion process (as is
required by NIH for the submission of unedited manuscripts per the agency's policy implementation
guidelines). In addition to providing readers the benefit of immediate open access, the author's pursuit
of the ACS AuthorChoice option ensures that the article included in PubMed Central corresponds to the
final published article of record as made available by the ACS. Stated NIH policy allows authors who
elect this option to use grant or contract funds in payment of open access publishing fees levied in
connection with ACS AuthorChoice. Details about the ACS AuthorChoice option are available at
• Option B: The author deposits the final, peer-reviewed manuscript with NIH, for open availability
12 months after publication. For those authors who do not wish to avail themselves of the ACS
AuthorChoice benefits, this option provides a no-fee mechanism by which authors may comply fully
with the requirements of the NIH Policy mandate. Accordingly, by pursuing this option, ACS authors
can themselves submit final peer-reviewed manuscripts to NIH in order to comply with the NIH Public
Access mandate, thus retaining control for making their deposits to the NIH submission system, and
assuming the responsibility of proofreading of converted files as required by NIH's own manuscript
processing procedures for such submissions. ACS authors will be notified upon publication of their
articles on the ACS Web site.
• Option C: ACS deposits on behalf of the author the final, peer-reviewed manuscript with NIH, for
open availability 12 months after publication. This service is provided at no charge to ACS
members in good standing and invoiced at a fee of $100 for non-members. As with Option B above,
NIH requires that authors proof and verify that that files converted by the NIH Manuscript Submission
are faithful to the accepted peer-reviewed manuscript.
To avoid any misperception that editorial acceptance of manuscripts might be affected by the author’s exercise
of the fee-based ACS AuthorChoice option, NIH-funded authors will be asked to sign the Addendum [PDF] and
indicate their choice of Options A, B, or C only after their peer-reviewed manuscripts are received from journal
editorial offices by our Columbus-based Production staff.
As a scholarly society deeply concerned with the integrity of the scientific record, ACS will continue to work
directly with the NIH to clarify the placement of appropriate notices and disclaimers, Internet links, and other
in place arrangements whereby any manuscript or article versions deposited with PubMed Central is linked by
NIH to the definitive published article as displayed from the ACS' own Web site. It is our understanding that the
NIH shall implement the public access policy in a manner consistent with copyright law. Regardless of which of
the above options an NIH funded author selects, the ACS reserves its rights under copyright to the content of
the peer-reviewed journal article. We trust that you appreciate that it is part of our responsibility in upholding
the integrity of the peer-reviewed scientific literature and maintaining the role of the journal as the source of the
authoritative version of the article.
Please do not hesitate to contact the ACS Copyright office or the ACS Publications Help Desk with any
questions about the use of the Addendum [PDF].
ACS Copyright Office ACS Publications Help Desk
E-mail: firstname.lastname@example.org E-mail: email@example.com
Phone: (202) 872-4367 Phone: (202) 872-4357 or (800) 227-9919 (toll-free)
The Scientific Record and Benefits for ACS Authors
As a scholarly society deeply concerned with the integrity of the scientific record, the ACS appreciates this
opportunity to reiterate that the Society fully supports the broad and sustainable dissemination of the
authoritative record of science found in our journals.
• Researchers, faculty, and students at institutions worldwide enjoy access to articles published in ACS
journals through institutional subscriptions at pricing specifically tailored for the different sizes, types,
and geographical locations of their institutions. ACS members may exercise the privilege of subscribing
to print and electronic journals at substantial discounts.
• Any non-subscriber may purchase an individual article of interest for a nominal fee or obtain an article
free of charge on request via interlibrary loan.
• Through the ACS Articles on Request program, any ACS author can e-mail or post a link on personal or
institutional Web sites to direct readers to the published version of the final article on the ACS Web site,
with no fee entailed. Readers who do not have subscription access privileges enjoy seamless access
readily via these author-directed links, with unlimited article downloads provided 12 months after article
• ACS authors may choose to participate in the ACS AuthorChoice fee-based open access licensing
option, which provides unrestricted Web access to their published ACS article at the time of publication,
and permits the posting of copies of final published articles on authors’ personal Web site and
institutional repositories for non-commercial scholarly purposes. ACS AuthorChoice fees compare very
favorably with fees for equivalent services offered by non-ACS journals, and are heavily discounted for
authors at subscribing institutions and/or those who are ACS members.
• Authors worldwide appreciate the benefit of publishing in the Society’s preeminent journals without the
need to pay any manuscript submission or processing fees, page charges, or color reproduction costs.
Copyright © 2009 American Chemical Society